3861 results for «2574»
3861 results
Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE
20 May 2025 – From EuroPCR 2025
Discover the latest evidence on the Supraflex thin-strut sirolimus DES in complex cases—from small vessels and diabetes to STEMI—supported by OCT analysis. This session highlights Supraflex’s performance in high bleeding risk and elderly patients, featuring data from FIRE, COMPARE, EARTH HBR, and Cruz Senior studies. Get...
How do I confidently expand my drug-coated balloon practice?
21 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session challenges the conventional approach to bifurcation PCI and dissection management. Learn why drug-coated balloons (DCB) may offer better long-term outcomes in cases where stents fall short, how DCBs can simplify bifurcation strategies, and why it’s time to rethink which dissections really need...
Symplicity Spyral renal denervation: more insights from clinical practice
21 May 2025 – From EuroPCR 2025
Renal denervation is gaining momentum in the management of hypertension. This EuroPCR 2025 session brings together long-term clinical experience and practical guidance on using the Symplicity Spyral™ system. Learn how to apply the latest European guidelines in daily practice, pick up valuable procedural tips from over...
How to handle the most clinically relevant challenges in TAVI
21 May 2025 – From EuroPCR 2025
This session explores some of the most clinically complex scenarios encountered in TAVI practice. Three real-world cases address key challenges such as intervention sequencing and transcatheter valve selection in patients with combined coronary artery disease and severe aortic stenosis. The session also examines coronary obstruction risk assessment and...
The future is now: QFR and RMS to optimise coronary artery disease patient management
20 May 2025 – From EuroPCR 2025
See how next-generation technologies are reshaping coronary artery disease treatment in this EuroPCR 2025 session. Learn how QFR is being used to plan PCI and evaluate results, and discover new insights into RMS technology—offering a potential leap beyond traditional drug-eluting stents. From practical case experience to...
The impact of paravalvular leak, permanent pacemaker implantation and the planning for reinterventions on lifetime management in TAVI patients
22 May 2025 – From EuroPCR 2025
How do paravalvular leak, pacemaker implantation and reintervention planning shape lifetime outcomes in TAVI patients?
This session examines these crucial aspects through the case of a 77-year-old male with bicuspid aortic valve stenosis, HFpEF and multiple comorbidities, including diabetes, obesity and sleep apnoea.
Follow the discussion to understand...
The Landmark RCT - One-year results
21 May 2025 – From EuroPCR 2025
This session presents a detailed analysis of a landmark randomized controlled trial evaluating the Myval transcatheter aortic valve implantation (TAVI) system among other contemporary transcatheter valves. The discussion centers on one-year clinical outcomes, with a particular focus on women, patients with small aortic annuli, and those...
The new global era of patient care with CathWorks FFRangio
22 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session highlights how CathWorks FFRangio is reshaping coronary physiology assessment worldwide. Through case-based experience and real-world data, it showcases the integration of FFRangio into routine clinical workflows—from early adoption at Clinique Pasteur in Toulouse to implementation across the UK. The session also presents...
The role of large-bore thrombectomy in my approach to pulmonary embolism management
21 May 2025 – From EuroPCR 2025
This session provides an in-depth overview of the use of large-bore thrombectomy in the management of pulmonary embolism. It highlights key clinical considerations for intervention, including the potential to reduce fatal events, prevent long-term complications, and optimize cost-effectiveness in eligible patients. A real-life case involving a 65-year-old patient...
Transforming PCI: mastering the implementation of drug-eluting balloons
22 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session provides a comprehensive overview of drug-eluting balloons (DEBs) and their growing role in percutaneous coronary intervention (PCI). Gain a clear understanding of the clinical evidence and rationale supporting DEBs, including how these devices minimize metal implantation and effectively treat both standard and...
Treat calcium right the first time: new considerations for PCI planning and device selection to optimise outcomes
21 May 2025 – From EuroPCR 2025
Watch this EuroPCR 2025 session to learn how intravascular lithotripsy (IVL) is transforming the management of coronary artery calcification (CAC). Discover the new CALC roadmap, a comprehensive framework guiding device selection and treatment strategies based on calcium burden, anatomy, and patient gender. Follow a real-world clinical...
Treating complex CAD indications with sirolimus coated balloon: evidence and performance
22 May 2025 – From EuroPCR 2025
Gain a deeper understanding of how sirolimus coated balloon (SCB) technology is shaping the treatment of complex coronary artery disease (CAD). This EuroPCR 2025 session brings together compelling clinical trial data and real-world case presentations to illustrate the safety, efficacy, and versatility of the MagicTouch SCB...
Ultrasound renal denervation is now guideline-recommended: how do I get started?
20 May 2025 – From EuroPCR 2025
Ultrasound renal denervation (uRDN) is now guideline-recommended—are you ready to bring it into practice? This EuroPCR 2025 session offers everything you need to get started: review key results from Sham-controlled and off-medication trials confirming the efficacy and safety of RDN; understand why both the ESC and...
Valve choice - Shaping index procedures and lifetime patient management
22 May 2025 – From EuroPCR 2025
This session addresses recent advancements and ongoing challenges in transcatheter aortic valve implantation (TAVI), with a particular focus on valve selection during index procedures. Presentations include data from the Accurate IDE trial, highlighting the prognostic implications of valve underexpansion. A clinical case involving an 80-year-old patient with severe...
Why should laser atherectomy be part of your complex PCI algorithm?
21 May 2025 – From EuroPCR 2025
Watch this EuroPCR 2025 session to see how ELCA can make the difference in two challenging cases: a severely calcified, undilatable lesion, and an uncrossable one. Learn how pre- and peri-procedural imaging (CT, IVUS, OCT) supports tailored decision-making, and how ELCA enables safe and effective lesion...
How a new generation of coronary sinus reducer can significantly expand treatment options for patients with coronary microvascular dysfunction
21 May 2025 – From EuroPCR 2025
Discover the latest on managing coronary microvascular dysfunction (CMD) with insights from EuroPCR 2025. This session explores how physiology testing helps identify CMD endotypes in the cathlab and highlights the limitations of ETT for patients experiencing angina or dyspnea at rest. Learn about the A-FLUX coronary...
Personalised Vascular Care Award - Competition
20 May 2025 – From EuroPCR 2025
Celebrate innovation in personalised vascular care through this award competition session. Presentations cover topics including coronary revascularisation decision-making, INOCA prevalence, endothelial shear stress, bifurcation stenting predictors, CT plaque analysis, and early STEMI discharge protocols.
Complex PCI in a TAVI patient - LIVE case
20 May 2025 – From EuroPCR 2025
An 84-year-old patient with a history of ischemic stroke in 2017, hypertension, diabetes, dyslipidemia, and a preserved LV function (63 %) presented with a severe symptomatic aortic stenosis. The coronary angiography revealed a severe and calcified stenosis of the distal left main.
Operators implanted an Edwards Sapien...
TAVI in bicuspid aortic valve disease - LIVE Case
20 May 2025 – From EuroPCR 2025
A 79-year-old male patient with atrial fibrillation and RBBB on ECG presented with symptomatic severe bicuspid aortic stenosis. LV function was preserved, and coronary artery disease was noted in LAD and first diagonal. A 26 mm Sapien Ultra Resilia valve was implanted via dual femoral access,...
Prevention of coronary obstruction during TAV-in-TAV
20 May 2025 – From EuroPCR 2025
Examine advanced techniques to prevent coronary obstruction during transcatheter aortic valve-in-valve (TAV-in-TAV) procedures. This session presents complex case strategies including the debated chimney technique and the UNICORN procedure designed for high coronary obstruction risk during redo TAVI interventions.
